Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 12, Issue 12, Pages 1923-1941
Publisher
Informa Healthcare
Online
2015-12-03
DOI
10.1517/17425247.2015.1069815
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Network of hypothalamic neurons that control appetite
- (2015) Jong-Woo Sohn BMB Reports
- Increased neurotrophic factor levels in ventral mesencephalic cultures do not explain the protective effect of osteopontin and the synthetic 15-mer RGD domain against MPP+ toxicity
- (2015) Lauren Broom et al. EXPERIMENTAL NEUROLOGY
- The neuroprotective effect of erythropoietin on experimental Parkinson model in rats
- (2015) Oytun Erbaş et al. NEUROPEPTIDES
- Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats
- (2015) T.S. Bender et al. NEUROSCIENCE
- Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats
- (2015) Federica Calcagnoli et al. PSYCHONEUROENDOCRINOLOGY
- Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice
- (2014) L. H. Vähätalo et al. Acta Physiologica
- Osteopontin – A multi-modal marker and mediator in atherosclerotic vascular disease
- (2014) Talya Wolak ATHEROSCLEROSIS
- The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
- (2014) Sara Lena Weinhold et al. BEHAVIOURAL BRAIN RESEARCH
- Early Intervention With Intranasal NPY Prevents Single Prolonged Stress-Triggered Impairments in Hypothalamus and Ventral Hippocampus in Male Rats
- (2014) Marcela Laukova et al. ENDOCRINOLOGY
- Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain
- (2014) B T Harmon et al. GENE THERAPY
- Intranasal nerve growth factor attenuates tau phosphorylation in brain after traumatic brain injury in rats
- (2014) Qiushi Lv et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson′s disease
- (2014) GerardW O′Keeffe et al. Neural Regeneration Research
- Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
- (2014) M.M. Migliore et al. NEUROSCIENCE
- Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease
- (2014) Ya Feng et al. NEUROSCIENCE LETTERS
- The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta)
- (2014) Sara M. Freeman et al. PSYCHONEUROENDOCRINOLOGY
- Biology of adeno-associated viral vectors in the central nervous system
- (2014) Giridhar Murlidharan et al. Frontiers in Molecular Neuroscience
- Effects of Intranasal Oxytocin on the Neural Basis of Face Processing in Autism Spectrum Disorder
- (2013) Gregor Domes et al. BIOLOGICAL PSYCHIATRY
- Intranasal oxytocin effects on social cognition: A critique
- (2013) Simon L. Evans et al. BRAIN RESEARCH
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2013) Jessica Freiherr et al. CNS DRUGS
- A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
- (2013) Bruce H. Morimoto et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model
- (2013) L.I. Serova et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model
- (2013) Xinmiao Ren et al. EXPERIMENTAL NEUROLOGY
- Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimer’s disease
- (2013) Tangui Maurice et al. JOURNAL OF PSYCHOPHARMACOLOGY
- IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice
- (2013) Carla Lopes et al. MOLECULAR NEUROBIOLOGY
- Trophic Factor Gene Therapy for Parkinson's Disease
- (2013) Jeffrey H. Kordower et al. MOVEMENT DISORDERS
- Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats
- (2013) Ying-Zheng Zhao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Intranasal epidermal growth factor treatment rescues neonatal brain injury
- (2013) Joseph Scafidi et al. NATURE
- Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats
- (2013) L.I. Serova et al. NEUROSCIENCE
- Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease
- (2013) X. Yue et al. NEUROSCIENCE
- Intranasal oxytocin selectively attenuates rhesus monkeys’ attention to negative facial expressions
- (2013) Lisa A. Parr et al. PSYCHONEUROENDOCRINOLOGY
- Effects of single dose intranasal oxytocin on social cognition in schizophrenia
- (2013) Michael C. Davis et al. SCHIZOPHRENIA RESEARCH
- Nasal Administration of Recombinant Osteopontin Attenuates Early Brain Injury After Subarachnoid Hemorrhage
- (2013) Basak Caner Topkoru et al. STROKE
- Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
- (2013) Susanne Bäck et al. Brain and Behavior
- Intranasal Oxytocin Blocks Alcohol Withdrawal in Human Subjects
- (2012) Cort A. Pedersen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats
- (2012) Lili Tian et al. BRAIN RESEARCH
- Intranasal delivery of nerve growth factor attenuates aquaporins-4-induced edema following traumatic brain injury in rats
- (2012) Qiushi Lv et al. BRAIN RESEARCH
- Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
- (2012) Seyed Khosrow Tayebati et al. CURRENT PHARMACEUTICAL DESIGN
- Intranasal delivery of growth differentiation factor 5 to the central nervous system
- (2012) Leah R. Hanson et al. DRUG DELIVERY
- Neurodevelopmental effects of insulin-like growth factor signaling
- (2012) John O’Kusky et al. FRONTIERS IN NEUROENDOCRINOLOGY
- TrkA Gene Ablation in Basal Forebrain Results in Dysfunction of the Cholinergic Circuitry
- (2012) E. Sanchez-Ortiz et al. JOURNAL OF NEUROSCIENCE
- Intranasal delivery of insulin via the olfactory nerve pathway
- (2012) Dan B. Renner et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Progressive dopamine and hypocretin deficiencies in Parkinson’s disease: is there an impact on sleep and wakefulness?
- (2012) MIRIAM WIENECKE et al. JOURNAL OF SLEEP RESEARCH
- Lysosomal enzyme can bypass the blood–brain barrier and reach the CNS following intranasal administration
- (2012) Daniel A. Wolf et al. MOLECULAR GENETICS AND METABOLISM
- Insulin-like growth factors in the brain and their potential clinical implications
- (2012) E. E. Benarroch NEUROLOGY
- Multifaces of neuropeptide Y in the brain – Neuroprotection, neurogenesis and neuroinflammation
- (2012) J.O. Malva et al. NEUROPEPTIDES
- Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
- (2012) Isobel J. Sleeman et al. NEUROPHARMACOLOGY
- Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
- (2012) Simona Capsoni et al. PLoS One
- Intranasal oxytocin increases covert attention to positive social cues
- (2012) G. Domes et al. PSYCHOLOGICAL MEDICINE
- Intranasal oxytocin attenuates the cortisol response to physical stress: A dose–response study
- (2012) Christopher Cardoso et al. PSYCHONEUROENDOCRINOLOGY
- Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia
- (2012) David Feifel et al. SCHIZOPHRENIA RESEARCH
- Intranasal delivery of biologics to the central nervous system
- (2011) Jeffrey J. Lochhead et al. ADVANCED DRUG DELIVERY REVIEWS
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease
- (2011) K. Stahl et al. BRAIN RESEARCH
- Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia
- (2011) Wusheng Zhu et al. DRUG DELIVERY
- Intranasal delivery of therapeutic proteins for neurological diseases
- (2011) Francesca Malerba et al. Expert Opinion on Drug Delivery
- Potential therapeutic uses of BDNF in neurological and psychiatric disorders
- (2011) Alan H. Nagahara et al. NATURE REVIEWS DRUG DISCOVERY
- Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
- (2011) H.-J. Jan et al. NEURO-ONCOLOGY
- Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease
- (2011) Mickael Decressac et al. NEUROBIOLOGY OF AGING
- Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
- (2011) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress Disorder
- (2011) Hagit Cohen et al. NEUROPSYCHOPHARMACOLOGY
- Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain
- (2011) Z. Cai et al. NEUROSCIENCE
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor
- (2011) A.M. Fletcher et al. NEUROSCIENCE
- A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain
- (2011) Y. Jiang et al. NEUROSCIENCE
- Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease
- (2011) Torsten Falk et al. NEUROSCIENCE LETTERS
- Neurorestoration
- (2011) Mikko Airavaara et al. PARKINSONISM & RELATED DISORDERS
- Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain
- (2011) Narendra K. Sharma et al. PEPTIDES
- Acute intranasal oxytocin improves positive self-perceptions of personality
- (2011) Christopher Cardoso et al. PSYCHOPHARMACOLOGY
- Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
- (2011) P.C. Baier et al. SLEEP MEDICINE
- Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia
- (2011) Yamila Rodríguez Cruz et al. TheScientificWorldJOURNAL
- Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment
- (2010) Gary B. Kaplan et al. BEHAVIOURAL PHARMACOLOGY
- Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients
- (2010) David Feifel et al. BIOLOGICAL PSYCHIATRY
- Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures
- (2010) Claudia Ganser et al. EXPERIMENTAL CELL RESEARCH
- Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease
- (2010) Merja H. Voutilainen et al. EXPERIMENTAL NEUROLOGY
- Intranasal erythropoietin therapy in nervous system disorders
- (2010) Sermin Genc et al. Expert Opinion on Drug Delivery
- The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
- (2010) Torsten Falk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra
- (2010) Joanna Iczkiewicz et al. JOURNAL OF NEUROCHEMISTRY
- A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
- (2010) Sheila M. Fleming et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats
- (2010) Y. Jiang et al. NEUROSCIENCE
- Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders
- (2009) Adam J. Guastella et al. BIOLOGICAL PSYCHIATRY
- Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats
- (2009) Shuying Lin et al. EXPERIMENTAL NEUROLOGY
- AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease
- (2009) Y-Q Xue et al. GENE THERAPY
- Manipulation of the oxytocin system alters social behavior and attraction in pair-bonding primates, Callithrix penicillata
- (2009) Adam S. Smith et al. HORMONES AND BEHAVIOR
- Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS
- (2009) Sandra R. Alcalá-Barraza et al. JOURNAL OF DRUG TARGETING
- Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease
- (2009) M. H. Voutilainen et al. JOURNAL OF NEUROSCIENCE
- Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations
- (2009) Mattia M. Migliore et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
- (2009) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
- (2009) David M Yurek et al. MOLECULAR THERAPY
- The dose-effectiveness of intranasal VEGF in treatment of experimental stroke
- (2009) Ji-Ping Yang et al. NEUROSCIENCE LETTERS
- Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina
- (2009) Xi-Qin Ding et al. PLoS One
- Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1)
- (2008) Paul Christian Baier et al. BRAIN
- Brain-derived neurotrophic factor, stress and depression: A minireview
- (2008) Burak Yuluğ et al. BRAIN RESEARCH BULLETIN
- Nasal Administration of Osteopontin Peptide Mimetics Confers Neuroprotection in Stroke
- (2008) Kristian P Doyle et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
- (2008) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Delivery of interferon-β to the monkey nervous system following intranasal administration
- (2008) R.G. Thorne et al. NEUROSCIENCE
- Direct transport of VEGF from the nasal cavity to brain
- (2008) Ji-Ping Yang et al. NEUROSCIENCE LETTERS
- Intranasal insulin attenuates the hypothalamic–pituitary–adrenal axis response to psychosocial stress
- (2008) Andreas Bohringer et al. PSYCHONEUROENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now